default author photo

Miquel Pavon

Gran Via de l'Hospitale

Barcelona

Spain

SCHOLARLY PAPERS

5

DOWNLOADS

417

TOTAL CITATIONS

0

Scholarly Papers (5)

Actions:
Email selected abstracts
1.

Immunogenicity and Safety Results Comparing Single Dose Human Papillomavirus Vaccine with Two or Three Doses in Tanzanian Girls - the DoRIS Randomised Trial

Number of pages: 130 Posted: 11 Mar 2022
Deborah Watson-Jones, John Changalucha, Hilary Whitworth, Ligia A. Pinto, Paul Mutani, Jackton Indangasi, Troy J. Kemp, Ramadhan Hashim, Beatrice Kamala, Rebecca Wiggins, Twaib Songoro, Nicholas Connor, Gladys Mbwanji, Miquel Pavon, Brett Lowe, Devis Mmbando, Saidi Kapiga, Philippe Mayaud, Silvia de SanJosé, Joakim Dillner, Richard J. Hayes, Charles Lacey and Kathy Baisley
Mwanza Intervention Trials Unit, Mwanza Intervention Trials Unit, Mwanza Intervention Trials Unit, Government of the United States of America - HPV Serology Laboratory, Mwanza Intervention Trials Unit, Mwanza Intervention Trials Unit, Government of the United States of America - HPV Serology Laboratory, National Institute for Medical Research (NIMR) - Mwanza Medical Research Centre, Mwanza Intervention Trials Unit, University of York, Mwanza Intervention Trials Unit, London School of Hygiene & Tropical Medicine, Mwanza Intervention Trials Unit, Gran Via de l'Hospitale, London School of Hygiene & Tropical Medicine, Mwanza Intervention Trials Unit, Mwanza Intervention Trials Unit, London School of Hygiene & Tropical Medicine - Department of Clinical Research, Institut Català d'Oncologia - Cancer Epidemiology Research Programme, Karolinska Institutet - Department of Laboratory Medicine, London School of Hygiene & Tropical Medicine - MRC International Statistics & Epidemiology Group, University of York - York Biomedical Research Institute and London School of Hygiene & Tropical Medicine - Faculty of Epidemiology and Population Health
Downloads 179 (422,345)

Abstract:

Loading...

HPV vaccine, dose schedules, immunogenicity, Africa

2.

Durability of Immunogenicity at 5 Years after a Single Dose of HPV Vaccine Compared with 2 Doses in Tanzanian Girls Aged 9-14 Years:  Results of the Long-Term Extension of the DoRIS Randomised Trial

Number of pages: 28 Posted: 23 Apr 2024
Deborah Watson-Jones, John Changalucha, Caroline Maxwell, Hilary Whitworth, Paul Mutani, Troy J. Kemp, Beatrice Kamala, Jackton Indangasi, George Constantine, Ramadhan Hashim, David Mwanzalima, Rebecca Wiggins, Devis Mmbando, Nicholas Connor, Miquel Pavon, Brett Lowe, Saidi Kapiga, Philippe Mayaud, Silvia de Sanjose, Joakim Dillner, Richard J. Hayes, Charles Lacey, Ligia A. Pinto and Kathy Baisley
Mwanza Intervention Trials Unit, Mwanza Intervention Trials Unit, Mwanza Intervention Trials Unit, Mwanza Intervention Trials Unit, Mwanza Intervention Trials Unit, Government of the United States of America - HPV Serology Laboratory, Mwanza Intervention Trials Unit, Mwanza Intervention Trials Unit, Mwanza Intervention Trials Unit, National Institute for Medical Research (NIMR) - Mwanza Medical Research Centre, Mwanza Intervention Trials Unit, University of York, Mwanza Intervention Trials Unit, London School of Hygiene & Tropical Medicine, Gran Via de l'Hospitale, London School of Hygiene & Tropical Medicine, Mwanza Intervention Trials Unit, London School of Hygiene & Tropical Medicine - Department of Clinical Research, National Institutes of Health, ISGlobal, Karolinska Institutet - Department of Laboratory Medicine, London School of Hygiene & Tropical Medicine - MRC International Statistics & Epidemiology Group, University of York - York Biomedical Research Institute, Government of the United States of America - HPV Serology Laboratory and London School of Hygiene & Tropical Medicine - Faculty of Epidemiology and Population Health
Downloads 103 (674,591)

Abstract:

Loading...

HPV vaccine, adolescent health, Tanzania, single dose

3.

Optimizing Anal High-Grade Squamous Intraepithelial Lesions Screening Strategies Using HPV DNA and E6/E7 mRNA Detection in Men Who Have Sex with Men Living with HIV

Number of pages: 19 Posted: 25 Sep 2023
Ana C. Silva-Klug, Sonia Paytubi, Montserrat Torres, Loris Trenti, Nuria Baixeras, Monica Sanchez-Llamas, Miquel Pavon, Silvia de Sanjose, Isabel Catalá, August Vidal, Mario Poljak, Laia Alemany, Daniel Podzamczer, Dr Sebastà Videla Cés and Maria Saumoy
Bellvitge University Hospital, Hospital Duran i Reynals (ICO) - Catalan Institute of Oncology, Carlos III Health Institute, Bellvitge University Hospital, Bellvitge University Hospital, Bellvitge University Hospital, Gran Via de l'Hospitale, National Institutes of Health, ISGlobal, Bellvitge University Hospital, Bellvitge University Hospital, University of Ljubljana - Institute of Microbiology and Immunology, Hospital Duran i Reynals (ICO) - Catalan Institute of Oncology, Bellvitge University Hospital, Bellvitge University Hospital and Bellvitge University Hospital - Department of Internal Medicine and Infectious Diseases
Downloads 62 (942,565)

Abstract:

Loading...

anal cancer screening, HSIL, HPV, High resolution anoscopy, viral biomarkers

4.

Hpv Self-Sampling Among Cervical Cancer Screening Users in Spain: A Randomized Clinical Trial of On-Site Training to Increase the Acceptability

Number of pages: 24 Posted: 03 Feb 2023
Raquel Ibáñez, Esther Roura, Amelia Acera, Miguel Andújar-Sánchez, Miquel Pavon, Laia Bruni and Silvia de Sanjose
Hospital Duran i Reynals (ICO) - Catalan Institute of Oncology, Hospital Duran i Reynals (ICO) - Catalan Institute of Oncology, Institut Català de la Salut, Complejo Hospitalario Universitario Insular-Materno Infantil, Gran Via de l'Hospitale, Hospital Duran i Reynals (ICO) - Catalan Institute of Oncology and National Institutes of Health, ISGlobal
Downloads 52 (1,041,696)

Abstract:

Loading...

HPV, self-sampling, acceptability, randomized clinical trial, on-site, training, Spain, cervical cancer, Screening, regular attenders

5.

Natural History of Anal HSIL and the Predictive Value of Anal Cytology and HPV Biomarkers for Incidence and Clearance in MSM Living with HIV: A Prospective Cohort Study

Number of pages: 25 Posted: 16 Mar 2026
Ana C. Silva-Klug, Sonia Paytubi, Loris Trenti, Monica Sanchez-Llamas, Nuria Baixeras, Gonzalo Peon, Sara Tous, Miquel Pavon, Montserrat Torres, Silvia De Sanjose, Jaime Vega-Costa, August Vidal, Laia Alemany, Daniel Podzamczer and Maria Saumoy
Bellvitge University Hospital, Hospital Duran i Reynals (ICO) - Catalan Institute of Oncology, Bellvitge University Hospital, Bellvitge University Hospital, University of Barcelona - Bellvitge University Hospital, Hospital Duran i Reynals (ICO) - Catalan Institute of Oncology, Hospital Duran i Reynals (ICO) - Catalan Institute of Oncology, Gran Via de l'Hospitale, Instituto de Salud Carlos III, Barcelona Institute for Global Health (ISGlobal), University of Barcelona - Bellvitge University Hospital, Bellvitge University Hospital, Hospital Duran i Reynals (ICO) - Catalan Institute of Oncology, Bellvitge University Hospital and Bellvitge University Hospital - Department of Internal Medicine and Infectious Diseases
Downloads 21 (1,436,435)

Abstract:

Loading...

HPV, HIV, HSIL, anal cancer, mRNA testing